1. Home
  2. DERM

DERM

Journey Medical Corporation

Logo Journey Medical Corporation

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-16-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

Founded: 2014 Country:
United States
United States
Employees: N/A City: SCOTTSDALE
Market Cap: 73.4M IPO Year: 2021
Target Price: $7.25 AVG Volume (30 days): 179.6K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.21 EPS Growth: N/A
52 Week Low/High: $1.02 - $8.11 Next Earning Date: 05-09-2024
Revenue: $79,181,000 Revenue Growth: 7.48%
Revenue Growth (this year): -25.27% Revenue Growth (next year): 41.42%

Share on Social Networks: